BiotechTube
Home/RyCarma Therapeutics/Jonathan Alspaugh
JA

Jonathan Alspaugh

President & Chief Strategy Officer

RyCarma Therapeutics

Therapeutic Areas

CardiovascularMusculoskeletal

RyCarma Therapeutics Pipeline

DrugIndicationPhase
SurlorianHeart FailurePhase 2
Rycal ProgramRyanodine Receptor 1-Related Myopathies (RYR1-RM)Preclinical

Leadership Team at RyCarma Therapeutics

AR
Adam Rosenberg
Chief Executive Officer
DA
Dr. Andrew Marks
Founder
View full RyCarma Therapeutics profile